Novartis

Topics • Strategy

Christophe Vidonne and Dr. Ralph Billo about Novartis' Buffer Management Concept

Topics

Novartis and Lilly Clinch Animal Health Deal

News

Novartis and GlaxoSmithKline Swap $20 Billion in Assets

News

Teva Asks U.S. Supreme Court to Stay Copaxone Ruling

News

Novartis Replaces Top Management in Japan After Clinical Trials Probe

News

Novartis Ends Heart Failure Drug Tests Early on Strong Results

News

U.S. Justices Agree to Hear Teva's Copaxone Appeal

News

Codexis Reports Fourth Quarter and Full Year 2013 Results

News

Bayer, Novartis said to Eye Merck & Co consumer health unit

News

Novartis Acquires U.S. Cancer Specialist CoStim

News

Swiss Anti-Immigration Vote Could Impact Chemical Sector

News

Novartis Said to Be Mulling a Jobs Shift to India

News

Fourth Ranbaxy Generics Plant Hit by FDA Ban

News

J&J Petitions FDA to Require ‘Similar’ Names For Biosimilars, Biologics

News

Bayer’s Eylea AMD Drug Hits Cost Evaluation Hurdle

News

EU Fines Drugmakers €16 million for Painkiller Delay

News

Boehringer Unit Taps Bank of America to Explore Sale of Generics Business

News

Novartis Overhauls Japanese Unit after Drug Scandal

News

Astrazeneca CEO Gets Two Cheers after First Year in Job

News

Syngenta May Be Template as Novartis Reviews Non-Core Assets

News

Novartis to Investigate Bribery Claims at Alcon Unit in China

News

China to Launch Fresh Pharmaceutical Bribery Probe

News

India Revokes GSK Cancer Drug Patent In Latest Big Pharma Blow

News

Europe Backs New Dual-Action Novartis Lung Drug

News

Bexsero Setback hits Novartis’ Vaccine Division

News

GSK Says Executives Appear To Have Broken Chinese law

123 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Special Issue

Explore the Future of Plastics

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.